JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Complementary and alternative medicine and the management of the metabolic syndrome.

More than one third of the population has the metabolic syndrome. Although aspects of the metabolic syndrome (MSDR) are readily treatable with evidence-based interventions, many patients and practitioners are looking for alternatives to pills and injectables. Complementary and alternative medicine may offer patients safe and effective options to target components of MSDR. This review covers the definition, pathophysiology, epidemiology, and population-based consequences of MSDR, defines complementary and alternative medicine, and applies evidence-based principles to the discussion of a number of alternative therapies purported to treat aspects of MSDR. It is time that the medical community becomes familiar with current fads in dietary supplements and nutraceuticals and begins to use the descriptors proven vs unproven in reference to alternative therapies. The proven alternative therapies discussed herein can provide a starting point for patients to gain ownership of their disease and to make positive choices into the future to halt the effects of MSDR.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app